PROVIDER PROFILE · NPI 1215194683
Sharon ChouMD
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
2,104
Unique beneficiaries
—
Total services
10,132
Distinct HCPCS
12
Medicare payment
$272K
Peer benchmark
Total Medicare services vs. 341 Endocrinology providers in MA — top quintile (cohort median 496).
PRESCRIBING · PART D · 2024
Total Rx claims
1,836
Beneficiaries
—
Total drug cost
$1.3M
Distinct drugs
20
Brand share
25.4%
Top prescribed drugs
Alendronate Sodium485 claims
Levothyroxine Sodium383 claims
Abaloparatide132 claims
Levothyroxine Sodium111 claims
Calcitriol98 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (5)
REFERRAL NETWORK
Where Sharon Chou's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 2 inbound referrers · 11 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| THE GENERAL HOSPITAL CORPORATION | 12 | 26 |
| Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA | 11 | 22 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| BRIGHAM & WOMENS HOSPITAL, INC. | 411 | 1,591 |
| BRIGHAM AND WOMEN'S FAULKNER HOSPITAL INC | 39 | 137 |
| Petr Jarolim Pathology · Boston, MA | 29 | 56 |
| DANA-FARBER CANCER INSTITUTE, INC. | 27 | 60 |
| MASSACHUSETTS EYE AND EAR INFIRMARY | 19 | 40 |
| Meryl Leboff Endocrinology · Boston, MA | 15 | 38 |
| NEWTON-WELLESLEY HOSPITAL | 13 | 32 |
| BETH ISRAEL DEACONESS MEDICAL CENTER, INC. | 13 | 26 |
| THE GENERAL HOSPITAL CORPORATION | 13 | 33 |
| Quest Diagnostics Massachusetts Llc Clinical Laboratory · Marlborough, MA | 11 | 24 |
| NPI 1215911060 | 11 | 20 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE